[Preventive interruption of the administration of HA-1A monoclonal antibody against endotoxin].
Torrabadella de Reynoso
P
P
Trilla
A
A
Salgado
A
A
Ribas
J
J
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D016470:Bacteremia / Q000188:drug therapy; D004731:Endotoxins / Q000276:immunology*; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy; D006801:Humans
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D004731:Endotoxins; C068069:nebacumab
Suspensión cautelar del anticuerpo monoclonal antiendotoxina HA-1A.